Cytosorbents Corporation (CTSO)
Company Info
| ISIN | US23283X2062 |
|---|---|
| CUSIP | 23283X206 |
| Sector | Healthcare |
| Industry | Medical Devices |
Highlights
| Market Cap | $49.40M |
|---|---|
| EPS | -$0.64 |
| PE Ratio | 9.02 |
| Revenue (TTM) | $36.35M |
| Gross Profit (TTM) | $20.73M |
| EBITDA (TTM) | -$28.81M |
| Year Range | $0.78 - $4.29 |
| Target Price | $3.70 |
| Short % | 2.94% |
| Short Ratio | 16.50 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Cytosorbents Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Cytosorbents Corporation had a return of -12.83% year-to-date (YTD) and -72.97% in the last 12 months. Over the past 10 years, Cytosorbents Corporation had an annualized return of -16.49%, while the S&P 500 had an annualized return of 10.99%, indicating that Cytosorbents Corporation did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -12.83% | 11.18% |
| 1 month | 22.48% | 5.60% |
| 6 months | -15.12% | 17.48% |
| 1 year | -72.97% | 26.33% |
| 5 years (annualized) | -32.53% | 13.16% |
| 10 years (annualized) | -16.49% | 10.99% |
Monthly Returns
The table below presents the monthly returns of CTSO, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -9.01% | -5.05% | -0.94% | -14.74% | -12.83% | ||||||||
| 2023 | 84.52% | 7.69% | 9.42% | -27.30% | 21.22% | 20.88% | -0.56% | -27.73% | -27.13% | -18.09% | -22.08% | -7.50% | -28.39% |
| 2022 | -11.22% | 4.03% | -17.57% | -34.17% | -8.10% | 13.47% | 4.11% | -16.67% | -28.42% | 37.50% | -25.13% | 10.71% | -63.01% |
| 2021 | 31.62% | -10.20% | -7.86% | 6.57% | -12.54% | -6.67% | 0.79% | 25.76% | -15.15% | -27.46% | -16.47% | -14.84% | -47.43% |
| 2020 | 28.31% | 22.06% | 28.19% | 10.74% | 19.28% | -3.04% | -3.28% | -11.85% | -5.51% | -4.08% | 9.67% | -5.01% | 107.01% |
| 2019 | -7.30% | 7.88% | -6.31% | -4.89% | -12.36% | 4.75% | 6.20% | -36.47% | 12.78% | -5.57% | -16.00% | -3.51% | -52.35% |
| 2018 | 16.92% | 3.29% | -10.19% | 7.09% | 49.67% | 0.88% | 5.26% | 22.08% | -11.95% | -22.48% | 4.40% | -22.61% | 24.31% |
| 2017 | 1.83% | 1.80% | -20.35% | 15.56% | -19.23% | 2.38% | 15.70% | 3.52% | 20.39% | -0.81% | 13.82% | -7.14% | 19.27% |
| 2016 | -31.06% | 34.37% | -24.03% | 10.20% | -0.69% | 6.06% | 7.69% | 2.24% | 27.74% | -7.81% | -12.71% | 5.83% | -2.15% |
| 2015 | -19.40% | 43.14% | 14.90% | -46.55% | -10.64% | -2.54% | 6.35% | 5.67% | -8.55% | 17.91% | -2.28% | -23.38% | -44.02% |
| 2014 | 124.00% | 7.14% | -23.33% | -0.43% | 6.99% | -1.22% | -0.41% | -4.56% | -0.04% | 2.22% | -14.04% | 97.03% | 218.40% |
| 2013 | -20.77% | 3.88% | 9.81% | -2.13% | 10.43% | -5.51% | -13.33% | -3.85% | 0.00% | 4.00% | 26.92% | -5.30% | -3.85% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of CTSO is 7, indicating that it is in the bottom 7% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
CTSO (Cytosorbents Corporation)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Cytosorbents Corporation (CTSO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Cytosorbents Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Cytosorbents Corporation was 99.21%, occurring on Nov 13, 2008. The portfolio has not yet recovered.
The current Cytosorbents Corporation drawdown is 98.98%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.21% | Aug 10, 2006 | 451 | Nov 13, 2008 | — | — | — |
Volatility
Volatility Chart
The current Cytosorbents Corporation volatility is 26.01%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |